These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24627238)

  • 21. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
    Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
    Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
    Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM
    Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients.
    Kageyama Y; Okada Y; Arai G; Hyochi N; Suzuki M; Masuda H; Hayashi T; Kawakami S; Okuno T; Ishizaka K; Kihara K
    Jpn J Clin Oncol; 2000 Dec; 30(12):553-6. PubMed ID: 11210165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen).
    Azuma H; Inamoto T; Takahara K; Nomi H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2013 Jul; 43(1):79-87. PubMed ID: 23624911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study.
    Miyanaga N; Akaza H; Okumura T; Sekido N; Kawai K; Shimazui T; Kikuchi K; Uchida K; Takeshima H; Ohara K; Akine Y; Ita Y
    Int J Urol; 2000 Feb; 7(2):41-8. PubMed ID: 10710246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder preservation by combined modality therapy for invasive bladder cancer.
    Kachnic LA; Kaufman DS; Heney NM; Althausen AF; Griffin PP; Zietman AL; Shipley WU
    J Clin Oncol; 1997 Mar; 15(3):1022-9. PubMed ID: 9060542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
    BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    Lian F; Chen W; Liu Y; Shen L; Fan W; Cui W; Zhao Y; Li J; Wang Y
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1625-1633. PubMed ID: 30900154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer.
    Ikushima H; Iwamoto S; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kubo A; Takegawa Y; Kudoh T; Kanayama H; Nishitani H
    Radiat Med; 2008 Apr; 26(3):156-63. PubMed ID: 18683571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiochemotherapeutic options for bladder cancer].
    Weiss C; Sauer R; Rödel C
    Aktuelle Urol; 2008 Mar; 39(2):123-9. PubMed ID: 18379965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy is an effective treatment for high-risk T1-bladder cancer.
    Rödel C; Dunst J; Grabenbauer GG; Kühn R; Papadopoulos T; Schrott KM; Sauer R
    Strahlenther Onkol; 2001 Feb; 177(2):82-8; discussion 89. PubMed ID: 11233839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Chetner MP; Souhami L; Zlotecki RA; Sause WT; True LD
    Oncologist; 2000; 5(6):471-6. PubMed ID: 11110598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
    Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H
    Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?
    Tachibana I; Bandali E; Calaway AC; Krishnan N; Cheng L; Adra N; Kaimakliotis HZ
    Urol Oncol; 2020 Nov; 38(11):850.e1-850.e7. PubMed ID: 32693973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer.
    Eapen L; Stewart D; Collins J; Peterson R
    J Urol; 2004 Oct; 172(4 Pt 1):1276-80. PubMed ID: 15371823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer.
    Liu Z; Ye Y; Li X; Guo S; Jiang L; Dong P; Li Y; Shi Y; Fan W; Cao Y; Yao K; Qin Z; Han H; Zhou F; Liu Z
    World J Urol; 2018 Aug; 36(8):1191-1200. PubMed ID: 29459997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neoadjuvant intra-arterial chemotherapy followed by partial cystectomy for invasive bladder cancer].
    Sekine H; Mine M; Ohya K; Kaneoya F; Yokokawa M
    Hinyokika Kiyo; 1992 Feb; 38(2):155-9. PubMed ID: 1561948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.